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Abstract
The	parathyroid	hormone	receptors	(nomenclature	as	agreed	by	the	NC-IUPHAR	Subcommittee
on	Parathyroid	Hormone	Receptors	[49])	are	class	B	G	protein-coupled	receptors.	The
parathyroid	hormone	(PTH)/parathyroid	hormone-related	peptide	(PTHrP)	receptor	(PTH1	receptor)
is	activated	by	precursor-derived	peptides:	PTH	(84	amino	acids),	and	PTHrP	(141	amino-acids)	and
related	peptides	(PTH-(1-34),	PTHrP-(1-36)).	The	parathyroid	hormone	2	receptor	(PTH2	receptor)	is
activated	by	the	precursor-derived	peptide	TIP39	(39	amino	acids).	[125I]PTH	may	be	used	to	label
both	PTH1	and	PTH2	receptors.	The	structure	of	a	long-active	PTH	analog	(LA-PTH,	an	hybrid	of
PTH-(1-13)	and	PTHrP-(14-36))	bound	to	the	PTH1	receptor-Gs	complex	has	been	resolved	by	cryo-
electron	microscopy	[147].	Another	structure	of	a	PTH-(1-34)	analog	bound	to	a	thermostabilized
inactive	PTH1	receptor	has	been	obtained	with	X-ray	crytallography	[34].
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